353 related articles for article (PubMed ID: 17001234)
1. Contrast-induced nephropathy in urgent coronary interventions.
Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
[TBL] [Abstract][Full Text] [Related]
2. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
3. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
4. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
6. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
Jabara R; Gadesam RR; Pendyala LK; Knopf WD; Chronos N; Chen JP; Viel K; King SB; Manoukian SV
Am J Cardiol; 2009 Jun; 103(12):1657-62. PubMed ID: 19539072
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
8. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
[TBL] [Abstract][Full Text] [Related]
9. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S
Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
[TBL] [Abstract][Full Text] [Related]
10. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
[TBL] [Abstract][Full Text] [Related]
11. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
Li WH; Li DY; Han F; Xu TD; Zhang YB; Zhu H
Int Urol Nephrol; 2013 Aug; 45(4):1065-70. PubMed ID: 23225080
[TBL] [Abstract][Full Text] [Related]
12. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
[TBL] [Abstract][Full Text] [Related]
13. Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.
Ji L; Su X; Qin W; Mi X; Liu F; Tang X; Li Z; Yang L
Nephrology (Carlton); 2015 Aug; 20(8):544-51. PubMed ID: 25706048
[TBL] [Abstract][Full Text] [Related]
14. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.
Maioli M; Toso A; Gallopin M; Leoncini M; Tedeschi D; Micheletti C; Bellandi F
J Cardiovasc Med (Hagerstown); 2010 Jun; 11(6):444-9. PubMed ID: 20164783
[TBL] [Abstract][Full Text] [Related]
15. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
Hernández F; Mora L; García-Tejada J; Velázquez M; Gómez-Blázquez I; Bastante T; Albarrán A; Andreu J; Tascón J
Rev Esp Cardiol; 2009 Dec; 62(12):1373-80. PubMed ID: 20038403
[TBL] [Abstract][Full Text] [Related]
16. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
[TBL] [Abstract][Full Text] [Related]
17. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
[TBL] [Abstract][Full Text] [Related]
18. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
[TBL] [Abstract][Full Text] [Related]
20. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
